Table 1.
Solitary plasmacytoma of bones: representative treatment results.
| Author | n | f/u | LC (%) | PMM (%) | OAS (%) |
|---|---|---|---|---|---|
| Wilder et al. [35] | 60 | 94 mo | 90 | 62 | 59 |
| Knobel et al. [25] | 206 | 56 mo | 79 | 51 | 50 |
| Tsang et al. [32] | 32 | 95 mo | 87 | 64 | 65 |
| Kilciksız et al. [24] | 57 | 2.4 y | 94 | 4.1 y | 68 |
| Frassica et al. [23] | 46 | 90 | 89 | 54 | 45 |
| Bataille and Sany [33] | 114 | >10 y | 88 | 58 | 68 |
| Galieni et al. [40] | 32 | 69 mo | 91 | 68 | 49 |
mo: months, y: years f/u: Median followup, LC: Local control (10-year rate), PMM: progression to myeloma (10-year rate), and OAS: over all survival (10- year rate).